The Forward P/E of Fusen Pharmaceutical Co Ltd (1652.HK) is N/A.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.